free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
Types of Multiple Myeloma | International Myeloma Foundation
Serum free light chain ratio predicts outcome in MGUS | Semantic Scholar
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
Living With - HealthTree for Multiple Myeloma
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory